Public Profile

Shouguang Fukang Pharmaceutical Co. Ltd

Shouguang Fukang Pharmaceutical Co. Ltd., a prominent player in the pharmaceutical industry, is headquartered in Shouguang, China. Established in 1998, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong focus on research and innovation, Shouguang Fukang has developed a diverse portfolio that includes both generic and proprietary drugs, setting itself apart through rigorous quality control and adherence to international standards. The company has earned a solid market position, recognised for its commitment to excellence and customer satisfaction. Operating primarily in Asia, Shouguang Fukang continues to expand its reach, contributing to the global healthcare landscape with its unique offerings and dedication to improving patient outcomes.

DitchCarbon Score

How does Shouguang Fukang Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

11

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Shouguang Fukang Pharmaceutical Co. Ltd's score of 11 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Shouguang Fukang Pharmaceutical Co. Ltd's reported carbon emissions

Shouguang Fukang Pharmaceutical Co. Ltd, headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. As Shouguang Fukang Pharmaceutical Co. Ltd moves forward, establishing clear climate commitments and reduction strategies will be crucial in aligning with industry standards and addressing climate change effectively.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shouguang Fukang Pharmaceutical Co. Ltd's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Shouguang Fukang Pharmaceutical Co. Ltd is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shouguang Fukang Pharmaceutical Co. Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Gulf Resources, Inc.

CN
Chemicals nec
Updated about 1 month ago

Shandong Xinhua Pharma

CN
Chemicals nec
Updated 13 days ago

Hunan Er-Kang Pharmaceutical Co., Ltd

CN
Chemicals nec
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers